Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clavulanic Acid for the Treatment of Cocaine Use Disorder
Sponsor: Temple University
Summary
A dose escalation study to assess the efficacy and safety of Clavulanic Acid (CLAV) vs. placebo (PBO) for the treatment of cocaine use disorder (CUD)
Official title: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Pilot Study to Assess the Efficacy and Safety of Clavulanic Acid vs. Placebo for the Treatment of Cocaine Use Disorder
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
65
Start Date
2023-05-03
Completion Date
2024-07
Last Updated
2024-05-02
Healthy Volunteers
No
Conditions
Interventions
Clavulanic Acid Only Product
Drug will be given in 250mg capsules
Placebo
Capsule with no active medication - identical to drug capsule
Locations (2)
University of Pennsylvania
Philadelphia, Pennsylvania, United States
MUSC
Charleston, South Carolina, United States